Camp4 Therapeutics Corp (CAMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 64,039 | 38,380 | 83,190 |
| TOTAL | $66,383 | $40,013 | $84,409 |
| Non-Current Assets | |||
| PPE Net | 3,858 | 4,797 | 5,648 |
| Investments And Advances | 427 | 748 | 376 |
| Other Non-Current Assets | 7,639 | 9,388 | 12,116 |
| TOTAL | $11,924 | $14,933 | $18,140 |
| Total Assets | $78,307 | $54,946 | $102,549 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 1,210 | 1,042 | 2,151 |
| Accrued Expenses | 4,833 | 3,302 | 3,425 |
| Other current liabilities | 85 | 405 | N/A |
| TOTAL | $9,598 | $7,807 | $7,946 |
| Non-Current Liabilities | |||
| Deferred Revenues | 385 | N/A | N/A |
| Other Non-Current Liabilities | 5,495 | 8,574 | 9,882 |
| TOTAL | $5,565 | $8,722 | $10,027 |
| Total Liabilities | $15,163 | $16,529 | $17,973 |
| Shareholders' Equity | |||
| Shares Outstanding, K | 20,161 | N/A | N/A |
| Common Shares | 2 | 1 | 1 |
| Retained earnings | -211,753 | -159,962 | -110,671 |
| TOTAL | $63,144 | $38,417 | $84,616 |
| Total Liabilities And Equity | $78,307 | $54,946 | $102,589 |